Development of targeted, theory-informed interventions to improve bronchiolitis management.

Behaviour change techniques Bronchiolitis De-implementation Intervention Theoretical domains framework

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
03 Aug 2021
Historique:
received: 03 03 2021
accepted: 16 06 2021
entrez: 4 8 2021
pubmed: 5 8 2021
medline: 6 8 2021
Statut: epublish

Résumé

Despite international guidelines providing evidence-based recommendations on appropriate management of infants with bronchiolitis, wide variation in practice occurs. This results in infants receiving care of no benefit, with associated cost and is potentially harmful. Theoretical frameworks are increasingly used to develop interventions, utilising behaviour change techniques specifically chosen to target factors contributing to practice variation, with de-implementation often viewed as harder than implementing. This paper describes the stepped process using the Theoretical Domains Framework (TDF) to develop targeted, theory-informed interventions which subsequently successfully improved management of infants with bronchiolitis by de-implementing ineffective therapies. Explicit description of the process and rationale used in developing de-implementation interventions is critical to dissemination of these practices into real world clinical practice. A stepped approach was used: (1) Identify evidence-based recommendations and practice variation as targets for change, (2) Identify factors influencing practice change (barriers and enablers) to be addressed, and (3) Identification and development of interventions (behaviour change techniques and methods of delivery) addressing influencing factors, considering evidence of effectiveness, feasibility, local relevance and acceptability. The mode of delivery for the intervention components was informed by evidence from implementation science systematic reviews, and setting specific feasibility and practicality. Five robust evidence-based management recommendations, targeting the main variation in bronchiolitis management were identified: namely, no use of chest x-ray, salbutamol, glucocorticoids, antibiotics, and adrenaline. Interventions developed to target recommendations addressed seven TDF domains (identified following qualitative clinician interviews (n = 20)) with 23 behaviour change techniques chosen to address these domains. Final interventions included: (1) Local stakeholder meetings, (2) Identification of medical and nursing clinical leads, (3) Train-the-trainer workshop for all clinical leads, (4) Local educational materials for delivery by clinical leads, (5) Provision of tools and materials targeting influencing factors, and prompting recommended behaviours, and (6) Audit and feedback. A stepped approach based on theory, evidence and issues of feasibility, local relevance and acceptability, was successfully used to develop interventions to improve management of infants with bronchiolitis. The rationale and content of interventions has been explicitly described allowing others to de-implement unnecessary bronchiolitis management, thereby improving care.

Sections du résumé

BACKGROUND BACKGROUND
Despite international guidelines providing evidence-based recommendations on appropriate management of infants with bronchiolitis, wide variation in practice occurs. This results in infants receiving care of no benefit, with associated cost and is potentially harmful. Theoretical frameworks are increasingly used to develop interventions, utilising behaviour change techniques specifically chosen to target factors contributing to practice variation, with de-implementation often viewed as harder than implementing. This paper describes the stepped process using the Theoretical Domains Framework (TDF) to develop targeted, theory-informed interventions which subsequently successfully improved management of infants with bronchiolitis by de-implementing ineffective therapies. Explicit description of the process and rationale used in developing de-implementation interventions is critical to dissemination of these practices into real world clinical practice.
METHODS METHODS
A stepped approach was used: (1) Identify evidence-based recommendations and practice variation as targets for change, (2) Identify factors influencing practice change (barriers and enablers) to be addressed, and (3) Identification and development of interventions (behaviour change techniques and methods of delivery) addressing influencing factors, considering evidence of effectiveness, feasibility, local relevance and acceptability. The mode of delivery for the intervention components was informed by evidence from implementation science systematic reviews, and setting specific feasibility and practicality.
RESULTS RESULTS
Five robust evidence-based management recommendations, targeting the main variation in bronchiolitis management were identified: namely, no use of chest x-ray, salbutamol, glucocorticoids, antibiotics, and adrenaline. Interventions developed to target recommendations addressed seven TDF domains (identified following qualitative clinician interviews (n = 20)) with 23 behaviour change techniques chosen to address these domains. Final interventions included: (1) Local stakeholder meetings, (2) Identification of medical and nursing clinical leads, (3) Train-the-trainer workshop for all clinical leads, (4) Local educational materials for delivery by clinical leads, (5) Provision of tools and materials targeting influencing factors, and prompting recommended behaviours, and (6) Audit and feedback.
CONCLUSION CONCLUSIONS
A stepped approach based on theory, evidence and issues of feasibility, local relevance and acceptability, was successfully used to develop interventions to improve management of infants with bronchiolitis. The rationale and content of interventions has been explicitly described allowing others to de-implement unnecessary bronchiolitis management, thereby improving care.

Identifiants

pubmed: 34344383
doi: 10.1186/s12913-021-06724-6
pii: 10.1186/s12913-021-06724-6
pmc: PMC8335893
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

769

Informations de copyright

© 2021. The Author(s).

Références

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000409
pubmed: 17943742
Cochrane Database Syst Rev. 2019 Jun 24;6:CD000125
pubmed: 31232458
Implement Sci. 2015 May 25;10:74
pubmed: 26003785
Implement Sci. 2019 Jan 17;14(1):4
pubmed: 30654826
Implement Sci. 2020 Jan 9;15(1):2
pubmed: 31915032
Implement Sci. 2012 May 31;7:50
pubmed: 22651257
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD001096
pubmed: 19588323
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Br J Health Psychol. 2015 Feb;20(1):130-50
pubmed: 24815766
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000259
pubmed: 22696318
JAMA. 2012 May 2;307(17):1801-2
pubmed: 22492759
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003030
pubmed: 19370580
Cochrane Database Syst Rev. 2015 Apr 29;(4):CD005470
pubmed: 25923419
J Pediatr Nurs. 2019 Jul - Aug;47:114-120
pubmed: 31108324
Pediatr Qual Saf. 2017 Dec 1;2(6):e046
pubmed: 30229182
Lancet. 2011 Nov 12;378(9804):1699-706
pubmed: 21996470
BMC Pediatr. 2018 Jul 6;18(1):218
pubmed: 29980177
BMJ Qual Saf. 2020 May;29(5):409-417
pubmed: 32029572
Implement Sci. 2013 May 16;8:52
pubmed: 23680355
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Pediatrics. 2018 Feb;141(2):
pubmed: 29321255
JAMA Pediatr. 2021 Aug 1;175(8):797-806
pubmed: 33843971
Pediatrics. 2017 Dec;140(6):
pubmed: 29184035
Lancet. 2017 Jan 14;389(10065):211-224
pubmed: 27549684
BMJ. 2015 Jun 02;350:h2305
pubmed: 26037525
J Paediatr Child Health. 2016 Feb;52(2):112-25
pubmed: 27062613
Emerg Med Australas. 2018 Jun;30(3):389-397
pubmed: 29573212
BMC Pediatr. 2020 May 1;20(1):189
pubmed: 32357866
Implement Sci. 2017 Jul 17;12(1):88
pubmed: 28716152
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Cochrane Database Syst Rev. 2012 Oct 17;10:CD004398
pubmed: 23076904
BMJ. 2008 Jan 12;336(7635):74-6
pubmed: 18187724
Pediatrics. 2014 Nov;134(5):e1474-502
pubmed: 25349312
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
Emerg Med Australas. 2006 Apr;18(2):143-7
pubmed: 16669940
Implement Sci. 2012 Apr 24;7:38
pubmed: 22531013
J Paediatr Child Health. 2019 Jan;55(1):42-53
pubmed: 30009459
Qual Saf Health Care. 2005 Feb;14(1):26-33
pubmed: 15692000
Health Technol Assess. 2004 Feb;8(6):iii-iv, 1-72
pubmed: 14960256
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986
Implement Sci. 2015 Jun 11;10:88
pubmed: 26062907
Pediatrics. 2014 Sep;134(3):571-81
pubmed: 25092947
Implement Sci. 2010 Feb 09;5:14
pubmed: 20181130

Auteurs

Libby Haskell (L)

Children's Emergency Department, Starship Children's Hospital, Private Bag 92024, Auckland, 1142, New Zealand. libbyh@adhb.govt.nz.
Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand. libbyh@adhb.govt.nz.

Emma J Tavender (EJ)

Clinical Sciences, Murdoch Children's Research Institute, Parkville, Melbourne, Victoria, Australia.
Departments of Paediatrics and Critical Care, University of Melbourne, Melbourne, Victoria, Australia.

Catherine L Wilson (CL)

Clinical Sciences, Murdoch Children's Research Institute, Parkville, Melbourne, Victoria, Australia.

Sharon O'Brien (S)

Emergency Department, Perth Children's Hospital, Perth, Western Australia, Australia.
Curtin University, Perth, Western Australia, Australia.

Franz E Babl (FE)

Clinical Sciences, Murdoch Children's Research Institute, Parkville, Melbourne, Victoria, Australia.
Departments of Paediatrics and Critical Care, University of Melbourne, Melbourne, Victoria, Australia.
Emergency Department, The Royal Children's Hospital, Melbourne, Victoria, Australia.

Meredith L Borland (ML)

Emergency Department, Perth Children's Hospital, Perth, Western Australia, Australia.
Divisions of Emergency Medicine and Paediatrics, School of Medicine, University of Western Austalia, Western Australia, Australia.

Elizabeth Cotterell (E)

Armidale Rural Referral Hospital, Armidale, New South Wales, Australia.
School of Rural Medicine, University of New England, Armidale, New South Wales, Australia.

Nicolette Sheridan (N)

College of Health, Massey University, Auckland, New Zealand.

Ed Oakley (E)

Clinical Sciences, Murdoch Children's Research Institute, Parkville, Melbourne, Victoria, Australia.
Departments of Paediatrics and Critical Care, University of Melbourne, Melbourne, Victoria, Australia.
Emergency Department, The Royal Children's Hospital, Melbourne, Victoria, Australia.

Stuart R Dalziel (SR)

Children's Emergency Department, Starship Children's Hospital, Private Bag 92024, Auckland, 1142, New Zealand.
Department of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand.
Department of Surgery, University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH